Universal Ibogaine Inc. (TSXV:IBO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0200
-0.0150 (-42.86%)
Jul 2, 2025, 3:58 PM EDT
100.00%
Market Cap 6.17M
Revenue (ttm) 2.06M
Net Income (ttm) -1.48M
Shares Out 308.61M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,165,727
Average Volume 90,577
Open 0.0350
Previous Close 0.0350
Day's Range 0.0200 - 0.0450
52-Week Range 0.0050 - 0.0450
Beta 6.56
RSI 75.81
Earnings Date Jun 27, 2025

About Universal Ibogaine

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Nicholas Karos
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol IBO
Full Company Profile

Financial Performance

In 2024, Universal Ibogaine's revenue was 2.33 million, an increase of 126.32% compared to the previous year's 1.03 million. Losses were -2.05 million, -14.17% less than in 2023.

Financial Statements

News

There is no news available yet.